Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
287
Appointments
163
Departures
21
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,399 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Inogen Inc | Andrew (“Andy”) P. Reding | Chief Operating OfficerCOO | Departed | Oct 30, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Troy A. Herring | member of the Board, Audit Committee and Compensation Committeemember of the Board, Audit Committee and Compensation Committee | Departed | Oct 31, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Livian L. Jones | member of the Board, Compensation Committee and Nominating and Governance Committeemember of the Board, Compensation Committee and Nominating and Governance Committee | Departed | Nov 2, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Mossadaq Chughtai | member of the Board, Audit Committee and Nominating and Governance Committeemember of the Board, Audit Committee and Nominating and Governance Committee | Departed | Nov 3, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Arthur Dammarrel | member of the Boardmember of the Board | Appointed | Nov 4, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Jon Vincent | member of the Boardmember of the Board | Appointed | Nov 4, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Millard “Flip” Wallen, III | PresidentPresident | Departed | Oct 30, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | John Vasilj | Chief Operating OfficerCOO | Appointed | Nov 4, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Mil L. “Flip” Wallen III | Chief Executive OfficerCEO | Departed | Oct 30, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Millard “Flip” Wallen, III | member of the board of directorsmember of the board of directors | Departed | Oct 30, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Troy A. Herring | member of the Board, Audit Committee and Compensation Committeemember of the Board, Audit Committee and Compensation Committee | Departed | Oct 31, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Livian L. Jones | member of the Board, Compensation Committee and Nominating and Governance Committeemember of the Board, Compensation Committee and Nominating and Governance Committee | Departed | Nov 2, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Mossadaq Chughtai | member of the Board, Audit Committee and Nominating and Governance Committeemember of the Board, Audit Committee and Nominating and Governance Committee | Departed | Nov 3, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Arthur Dammarrel | member of the Boardmember of the Board | Appointed | Nov 4, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | Jon Vincent | member of the Boardmember of the Board | Appointed | Nov 4, 2026 | SEC 8-K |
| Nov 5, 2026 | KiNRG, Inc. | John Vasilj | Chief Operating OfficerCOO | Appointed | Nov 4, 2026 | SEC 8-K |
| Nov 5, 2026 | Latigo Biotherapeutics, Inc. | Todd Smith | President and Chief Executive OfficerCEO | Appointed | Nov 3, 2026 | SEC 8-K |
| Nov 5, 2026 | Latigo Biotherapeutics, Inc. | Nima Farzan | President and Chief Executive OfficerCEO | Departed | Nov 3, 2026 | SEC 8-K |
| Nov 5, 2026 | Latigo Biotherapeutics, Inc. | Nima Farzan | member of the Boardmember of the Board | Departed | Nov 3, 2026 | SEC 8-K |
| Nov 5, 2026 | Longeveron Inc. | Ursula Ungaro | DirectorDirector | Departed | Nov 1, 2026 | SEC 8-K |
- Inogen IncDeparted
Andrew (“Andy”) P. Reding COO
Filed Nov 5, 2026Effective Oct 30, 2026SEC 8-K
- KiNRG, Inc.Departed
Troy A. Herring member of the Board, Audit Committee and Compensation Committee
Filed Nov 5, 2026Effective Oct 31, 2026SEC 8-K
- KiNRG, Inc.Departed
Livian L. Jones member of the Board, Compensation Committee and Nominating and Governance Committee
Filed Nov 5, 2026Effective Nov 2, 2026SEC 8-K
- KiNRG, Inc.Departed
Mossadaq Chughtai member of the Board, Audit Committee and Nominating and Governance Committee
Filed Nov 5, 2026Effective Nov 3, 2026SEC 8-K
- KiNRG, Inc.Appointed
Arthur Dammarrel member of the Board
Filed Nov 5, 2026Effective Nov 4, 2026SEC 8-K
- KiNRG, Inc.Appointed
Jon Vincent member of the Board
Filed Nov 5, 2026Effective Nov 4, 2026SEC 8-K
- KiNRG, Inc.Departed
Millard “Flip” Wallen, III President
Filed Nov 5, 2026Effective Oct 30, 2026SEC 8-K
- KiNRG, Inc.Appointed
John Vasilj COO
Filed Nov 5, 2026Effective Nov 4, 2026SEC 8-K
- KiNRG, Inc.Departed
Mil L. “Flip” Wallen III CEO
Filed Nov 5, 2026Effective Oct 30, 2026SEC 8-K
- KiNRG, Inc.Departed
Millard “Flip” Wallen, III member of the board of directors
Filed Nov 5, 2026Effective Oct 30, 2026SEC 8-K
- KiNRG, Inc.Departed
Troy A. Herring member of the Board, Audit Committee and Compensation Committee
Filed Nov 5, 2026Effective Oct 31, 2026SEC 8-K
- KiNRG, Inc.Departed
Livian L. Jones member of the Board, Compensation Committee and Nominating and Governance Committee
Filed Nov 5, 2026Effective Nov 2, 2026SEC 8-K
- KiNRG, Inc.Departed
Mossadaq Chughtai member of the Board, Audit Committee and Nominating and Governance Committee
Filed Nov 5, 2026Effective Nov 3, 2026SEC 8-K
- KiNRG, Inc.Appointed
Arthur Dammarrel member of the Board
Filed Nov 5, 2026Effective Nov 4, 2026SEC 8-K
- KiNRG, Inc.Appointed
Jon Vincent member of the Board
Filed Nov 5, 2026Effective Nov 4, 2026SEC 8-K
- KiNRG, Inc.Appointed
John Vasilj COO
Filed Nov 5, 2026Effective Nov 4, 2026SEC 8-K
- Latigo Biotherapeutics, Inc.Appointed
Todd Smith CEO
Filed Nov 5, 2026Effective Nov 3, 2026SEC 8-K
- Latigo Biotherapeutics, Inc.Departed
Nima Farzan CEO
Filed Nov 5, 2026Effective Nov 3, 2026SEC 8-K
- Latigo Biotherapeutics, Inc.Departed
Nima Farzan member of the Board
Filed Nov 5, 2026Effective Nov 3, 2026SEC 8-K
- Longeveron Inc.Departed
Ursula Ungaro Director
Filed Nov 5, 2026Effective Nov 1, 2026SEC 8-K